Valerie Mizrahi | |
---|---|
Born | 1958 (age 65–66) |
Citizenship | South African |
Known for | Tuberculosis |
Awards | L'Oréal-UNESCO Award, 2000 Order of Mapungubwe, 2007 |
Scientific career | |
Fields | Molecular biology |
Valerie Mizrahi FRS (born 1958) is a South African molecular biologist. [1]
The daughter of Morris and Etty Mizrahi, she was born in Harare, Zimbabwe and was educated there. Her family is a Sephardi Jewish family from the Greek island of Rhodes. [2]
She went on to earn a BSc in chemistry and mathematics and then a PhD in chemistry at the University of Cape Town. [3] From 1983 to 1986, she pursued post-doctoral studies at Pennsylvania State University. Mizrahi then worked in research and development for pharmaceutical company Smith, Kline & French. [1] In 1989, she established as research unit at the South African Institute for Medical Research and University of the Witwatersrand, remaining there until 2010. Her research has been focused on the treatment of tuberculosis, and drug resistance. [4] In 2011, she became director of the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town. [5] Mizrahi is director of a research unit of the South African Medical Research Council and leads the University of Cape Town branch of the Centre of Excellence in Biomedical TB Research. [3]
Mizrahi received the L'Oréal-UNESCO Award for Women in Science in 2000. In 2006, she received the Gold Medal from the South African Society for Biochemistry and Molecular Biology for her contributions to the field and the Department of Science and Technology's Distinguished Woman Scientist Award. She is a fellow of the Royal Society of South Africa, a member of the Academy of Science of South Africa [1] and a fellow of the American Academy of Microbiology since 2009. [6] She was named to the Order of Mapungubwe in 2007. From 2000 to 2010, she was an International Research Scholar of the Howard Hughes Medical Institute; in 2012, she was named a Senior International Research Scholar for the Institute until 2017. [3] In 2013, she was awarded the Institut de France's Christophe Mérieux Prize for her work in tuberculosis research. [7] Mizrahi was elected a Fellow of the Royal Society in 2023. [8]
Valerie has two daughters, and her father is the honorary president of the Johannesburg Sephardic Hebrew Congregation. She grew up speaking Judeo-Spanish at home. [2]
Bonnie Lynn Bassler is an American molecular biologist; the Squibb Professor in Molecular Biology and chair of the Department of Molecular Biology at Princeton University; and a Howard Hughes Medical Institute Investigator. She has researched cell-to-cell chemical communication in bacteria and discovered key insights into the mechanism by which bacteria communicate, known as quorum sensing. She has contributed to the idea that disruption of chemical signaling can be used as an antimicrobial therapy.
TB Alliance is a not-for-profit product development partnership (PDP) dedicated to the discovery and development of new, faster-acting and affordable tuberculosis (TB) medicines. Since its inception in 2000, TB Alliance has worked to grow the field of available treatments for TB and now manages the largest pipeline of new TB drugs in history. It was founded in Cape Town, South Africa, and has since expanded. It is headquartered in New York City and has a regional office in Pretoria.
The L'Oréal-UNESCO For Women in Science International Awards, created in 1998, aim to improve the position of women in science by recognizing outstanding women researchers who have contributed to scientific progress. The awards are a result of a partnership between the Foundation of the French company L'Oréal and the United Nations Educational, Scientific and Cultural Organization (UNESCO) and carry a grant of $100,000 USD for each laureate. This award is also known as the L'Oréal-UNESCO Women in Science Awards.
Philippa "Pippa" Marrack, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a distinguished professor of immunology and microbiology at the University of Colorado Denver.
The Harry Oppenheimer Fellowship Award is awarded annually by the Oppenheimer Memorial Trust. It is considered the top award for research on the African continent.
Jill Farrant, professor of molecular and cell biology at the University of Cape Town, South Africa, is a leading expert on resurrection plants, which 'come back to life' from a desiccated, seemingly dead state when they are rehydrated.
Firdausi Qadri is a Bangladeshi scientist with specialization in immunology and infectious disease research. She has worked over 25 years on the development of vaccines for cholera and has expertise on other infectious disease like ETEC, Typhoid, Helicobacter pylori, rotavirus, etc. Currently, she is working as a director for Centre for Vaccine Sciences of International Centre for Diarrhoeal Disease and Research, Bangladesh (ICDDR,B). She also serves as chairperson of the Institute for developing Science and Health initiatives. Her scientific achievements lie in enteric infections and vaccines including Vibrio cholerae and enterotoxigenic Escherichia coli—major causes of severe diarrhea. She has also focused on studying the immune response in Helicobacter pylori infected people in Bangladesh and the responses in patients with typhoid fever as well as vaccinees. The Government of Bangladesh awarded her the Independence Award in 2023.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Jennifer Ann Thomson is a South African microbiologist, author and most notably an expert on and proponent of the agricultural benefit of Genetically modified organisms (GMO). Thomson was born in Cape Town, South Africa and she is currently a professor at her alma mater the University of Cape Town.
Johannie Maria Spaan is a South African wildlife biologist.
Lalita Ramakrishnan is an Indian-born American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology, where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and 2019 Ramakrishnan coauthored two influential papers in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high. She is married to Mark Troll, a physical chemist.
Francine NtoumiPh.D., HDR, PvDz, FRCPedin is a Congolese parasitologist specializing in malaria. She was the first African person in charge of the secretariat of the Multilateral Initiative on Malaria (2006-2010). In recent years, she has become involved in research on other infectious diseases, including COVID-19.
Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a Professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is also Director of the Desmund Tutu HIV Centre at the University of Cape Town. She is a Past President of the International AIDS Society (2016-18).
Kirsten Bos is a Canadian physical anthropologist. She is Group Leader of Molecular Palaeopathology at the Max Planck Institute for Evolutionary Anthropology in Leipzig. Her research focuses on ancient DNA and infectious diseases.
Helen Irene McShane is a British infectious disease physician and a professor of vaccinology, in the Jenner Institute at the University of Oxford, where she has led the tuberculosis vaccine research group since 2001. She is senior research fellow at Harris Manchester College, Oxford.
Kathryn "Kat" Elizabeth Holt is an Australian computational biologist specializing in infectious disease genomics. She is a professor at Monash University's Department of Infectious Diseases and a professor of Microbial Systems Genomics at the London School of Hygiene & Tropical Medicine (LSHTM). Her current research focuses on investigating the evolution and dissemination of antimicrobial resistance. In 2015, Holt received the L'Oréal-UNESCO International Rising Talent Award.
Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.
Katie Jane Ewer is a British immunologist and Professor of Vaccine Immunology at the University of Oxford's Jenner Institute.
Mkunde Chachage is a lecturer and researcher in immunology at University of Dar es Salaam Mbeya College of Health and Allied Sciences. She is also a researcher at the National Institute for Medical Research at Mbeya medical research centre. She conducts research in clinical immunology as well as infectious diseases of human including Tuberculosis (TB), HIV and helminths infections.
Namrita Lall is an Indian–South African botanist and pharmacologist who is professor of plant sciences at the University of Pretoria. She is an expert in medicinal plant science. At the University of Pretoria, she holds the South African Research Chair for Plant Health Products from Indigenous Knowledge Systems and leads a research group that is active in bioprospecting, particularly in respect of cosmeceuticals and tuberculosis and cancer treatments.